LU90956I2
(fr )
2002-11-13
Metvix principe actif méthylaminolevulinique sous forme d'un selde préférence l'hyhrochlorure méthylaminolevulinique
LU90865I2
(fr )
2002-02-18
Hydrochlorure d sibutramine ses d-riv-s et ses sels pharmaceutiquement acceptables en particulier le monohydrate d'hydrochlorure de sibutramine
YU37301A
(sh )
2005-06-10
Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
CZ176595A3
(en )
1995-12-13
The application of anticonvulsive agents for the preparation of medicaments intended for treating parkinson's disease and parkinson's syndromes
ATE420090T1
(de )
2009-01-15
Chemokine-rezeptor-antagonisten und methoden zu deren anwendung
HUT76788A
(en )
1997-11-28
N-tert-butyl alfa-(2,4-disulfonyl)-phenyl nitrone, its salts, and their use for the preparation of pharmaceutical compositions
EP0459666A3
(en )
1992-06-03
Medicaments against impotence
GEP20043162B
(en )
2004-01-26
Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
Gøtzsche
1989
PATIENTS'PREFERENCE IN INDOMETHACIN TRIALS: AN OVERVIEW
MY124465A
(en )
2006-06-30
Reduction of infarct volume using citicoline
UA19156A
(uk )
1997-12-25
Спосіб одержаhhя амідіhів або їх фармацевтичhо прийhятhих солей
DE59501186D1
(de )
1998-02-05
Schutzkleidung, besonders antiballistische damen-schutzkleidung
EP1690545A3
(en )
2007-05-09
Preparation of Product R and product so obtained
Dooley et al.
1994
Layer rearrangement in coextrusion
SG165152A1
(en )
2010-10-28
Chemokine receptor antagonists and methods of use thereof
PL323305A1
(en )
1998-03-16
Applications of allyl amines
HUT74434A
(en )
1996-12-30
Oral dosage form containing colestipol as a carrier and acidic substances and a process for producing the same
TR199801669A2
(xx )
1999-03-22
Sodyum-hidrojen de�i�im inhibit�rlerinin bir ila� �retiminde kullan�m�.
DE602004011906D1
(de )
2008-04-03
Pharmazeutische zusammensetzung für die intrazelluläre ansäuerung mit cis-urocansäure
Scholz
2002
Some historical aspects of the development of cardiovascular drugs
DE3376327D1
(en )
1988-05-26
Spiro(2h-1,4-benzodioxepin-3(5h)4'-piperidine and 3'-pyrrolidino) compounds, a process for preparing the same and their use as medicaments
Tennant Jr et al.
1987
Step-Wise Withdrawal from Cocaine Depen
GB1454390A
(en )
1976-11-03
Nasal decongestants
GB1420976A
(en )
1976-01-14
Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
Neagu
1990
Bucharest's first family planning clinic since the revolution